Partner Content Partner Content SMi Group: Exclusive Speaker Interview with Professor Nagy H... RNA Therapeutics
Partner Content Partner Content Agenda released for SMi Group’s Controlled Release Delivery ... Agenda released for Controlled Release Delivery 2018
Partner Content Partner Content Pre-Filled Syringes Europe 2018 Attendee List Released Pre-Filled Syringes Europe 2018 Attendee List Released
Events Partner Content Controlled Release Delivery 2018 15th annual Controlled Release Delivery in London
Partner Content Partner Content Leveraging 4 Key Drivers at Pre-Filled Syringes Europe 2018 4 Key Drivers in a $6.36 Billion PFS Market
Partner Content Partner Content Q&A Released with West Pharmaceutical Services ahead of ... Interview released with West Pharmaceutical Services
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
